{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:11:35Z","timestamp":1780423895645,"version":"3.54.1"},"reference-count":21,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T00:00:00Z","timestamp":1357171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2013,5]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Factor VIII Inhibitor Bypassing Activity (<jats:styled-content style=\"fixed-case\">FEIBA<\/jats:styled-content>) can effectively achieve haemostasis in haemophilia patients with inhibitors. Further evaluation of <jats:styled-content style=\"fixed-case\">FEIBA<\/jats:styled-content> in surgical settings is of significant interest considering the relatively limited prospective data published to date. The aim of the study is to evaluate the perioperative efficacy and safety of <jats:styled-content style=\"fixed-case\">FEIBA<\/jats:styled-content> in haemophilia patients with inhibitors. Haemophilia patients with inhibitors who underwent surgical procedures and received <jats:styled-content style=\"fixed-case\">FEIBA<\/jats:styled-content> for perioperative haemostatic control were prospectively enrolled in an open\u2010label, noninterventional, postauthorization study [<jats:styled-content style=\"fixed-case\">SUR<\/jats:styled-content>gical interventions with <jats:styled-content style=\"fixed-case\">FEIBA<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">SURF<\/jats:styled-content>)]. Outcome measures included haemostatic efficacy, safety, <jats:styled-content style=\"fixed-case\">FEIBA<\/jats:styled-content> exposure and blood loss associated with the perioperative use of <jats:styled-content style=\"fixed-case\">FEIBA<\/jats:styled-content>. Thirty\u2010five surgical procedures were performed at 19 centres worldwide in patients with congenital haemophilia A, congenital haemophilia B, or acquired haemophilia A. Haemorrhagic risk was severe in 37.1% (13 of 35) of the procedures, moderate in 25.7% (9 of 35) and mild in 37.1% (13 of 35). One moderate risk surgery was excluded from the efficacy analyses because it did not meet all protocol requirements. Haemostasis was judged to be \u2018good\u2019 or \u2018excellent\u2019 in 91.2% (31 of 34) of surgical procedures and \u2018fair\u2019 in 8.8% (3 of 34). Among the 12 adverse events, three were serious adverse events (<jats:styled-content style=\"fixed-case\">SAE<\/jats:styled-content>s), two of which were unrelated to <jats:styled-content style=\"fixed-case\">FEIBA<\/jats:styled-content> therapy; one <jats:styled-content style=\"fixed-case\">SAE<\/jats:styled-content>, a clot in an arteriovenous fistula, was deemed to be possibly related to therapy. This prospective investigation confirms that <jats:styled-content style=\"fixed-case\">FEIBA<\/jats:styled-content> can be safely and effectively used when performing surgical procedures in haemophilia patients with inhibitors.<\/jats:p>","DOI":"10.1111\/hae.12080","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T08:49:24Z","timestamp":1357202964000},"source":"Crossref","is-referenced-by-count":32,"title":["<scp>SUR<\/scp>gical interventions with <scp>FEIBA<\/scp> (<scp>SURF<\/scp>): international registry of surgery in haemophilia patients with inhibitory antibodies"],"prefix":"10.1111","volume":"19","author":[{"given":"C.","family":"N\u00e9grier","sequence":"first","affiliation":[{"name":"H\u00f4pital \u00c9douard Herriot Lyon France"},{"name":"Universit\u00e9 Claude Bernard Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lienhart","sequence":"additional","affiliation":[{"name":"H\u00f4pital \u00c9douard Herriot Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Numerof","sequence":"additional","affiliation":[{"name":"Baxter Healthcare Corporation Westlake Village CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Stephens","sequence":"additional","affiliation":[{"name":"Baxter Healthcare Corporation Westlake Village CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Y.","family":"Wong","sequence":"additional","affiliation":[{"name":"Baxter Healthcare Corporation Westlake Village CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Baghaei","sequence":"additional","affiliation":[{"name":"Sahlgrenska University Hospital Gothenburg Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. T.","family":"Yee","sequence":"additional","affiliation":[{"name":"Royal Free Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,1,3]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-017988"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01136.x"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2003.00856.x"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2002.00532.x"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.00944.x"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1656122"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00938.x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00939.x"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2003.00857.x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.00299.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e318041f101"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02223.x"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02360.x"},{"key":"e_1_2_7_15_1","first-page":"60","article-title":"Control of bleeding in patients with inhibitors to factor VIII and IX undergoing surgical procedures","volume":"10","author":"Kraut EH","year":"2004","journal-title":"Haemophilia"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01873.x"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04173.x"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01284.x"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00935.x"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01840.x"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02329.x"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-291906"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhae.12080","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.12080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T16:36:42Z","timestamp":1697387802000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hae.12080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.1111\/hae.12080"],"URL":"https:\/\/doi.org\/10.1111\/hae.12080","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,3]]}}}